🇺🇸 FDA
Pipeline program

A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump.

NN1471-5026

Phase 1 other active

Quick answer

A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump. for Diabetes mellitus type 2 is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Diabetes mellitus type 2
Phase
Phase 1
Modality
other
Status
active

Clinical trials